Another batch of blood pressure medication has been recalled after trace amounts of a probable carcinogen was detected in the product. Prinston Pharmaceutical Inc. issued the recall for one lot of Irbesartan and seven lots of Irbesartan HCTZ tablets, which are used to control high blood pressure and to treat heart failure. According to the news release on the FDA’s website, NDEA occurs naturally in certain foods, water, pollution and industrial processes but it has been classified as a probable human carcinogen. The medications were distributed nationwide, and distributors and customers are being contacted immediately to discontinue distribution of the specific lots being recalled and to notify their sub accounts. CLICK HERE TO GET THE FOX NEWS APPIbesartan is being pulled weeks after Aurobindo Pharma Ltd recalled 80 lots of a blood pressure drug that was also found to have levels of NDEA that were found to be above the acceptable limit.

Source: Fox News January 22, 2019 14:26 UTC